PubRank

J W Ironside

Author PubWeight™ 206.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996 20.15
2 Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997 15.73
3 Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999 4.02
4 Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 2006 3.29
5 Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998 3.08
6 The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000 2.92
7 Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000 2.59
8 Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A 2000 2.46
9 Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000 2.42
10 Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995 2.10
11 Deaths from variant Creutzfeldt-Jakob disease. Lancet 1999 2.04
12 Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia 2010 2.03
13 High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997 2.00
14 Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001 1.84
15 Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996 1.66
16 Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol 2007 1.51
17 Gliosarcoma with areas of primitive neuroepithelial differentiation and extracranial metastasis. Clin Neuropathol 2001 1.49
18 Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010 1.45
19 Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest 1999 1.42
20 In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 2007 1.41
21 Progressive ataxia, focal seizures, and malabsorption syndrome in a 41 year old woman. J Neurol Neurosurg Psychiatry 1996 1.39
22 Creutzfeldt-Jakob disease: implications for gastroenterology. Gut 2002 1.38
23 The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999 1.31
24 Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001 1.30
25 Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004 1.26
26 The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 2005 1.22
27 Registration quality and descriptive epidemiology of childhood brain tumours in Scotland 1975-90. Br J Cancer 1994 1.18
28 Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 1993 1.18
29 Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 1998 1.17
30 Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride. J Pharm Pharmacol 1988 1.16
31 A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer 2000 1.16
32 Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 1994 1.14
33 Prion protein immunocytochemistry--UK five centre consensus report. Neuropathol Appl Neurobiol 1997 1.13
34 A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 2009 1.10
35 Neuronal apoptosis in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1999 1.09
36 Neuropathology of spongiform encephalopathies in humans. Br Med Bull 1993 1.08
37 Bovine spongiform encephalopathy and risk to health. BMJ 1992 1.08
38 DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates. J Neurosurg 1987 1.07
39 Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases. Neuropathol Appl Neurobiol 2000 1.05
40 The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry 2010 1.04
41 Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996 1.04
42 Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial. Eur J Cancer 2010 1.02
43 Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study. J Clin Pathol 1986 1.01
44 Identification and characterisation of 5-hydroxytryptamine 3 recognition sites in human brain tissue. J Neurochem 1989 0.98
45 Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 1999 0.98
46 Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet 1993 0.98
47 Pulmonary veno-occlusive disease. A report of four cases. Histopathology 1986 0.98
48 Histology of neuroblastoma involving bone marrow. Br J Haematol 1989 0.97
49 Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype. Ann Neurol 2001 0.97
50 Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol 2004 0.97
51 Review: Creutzfeldt-Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol 2012 0.97
52 Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 2003 0.96
53 Morphologic and immunophenotypic characterization of primary brain lymphomas using paraffin-embedded tissue. Histopathology 1989 0.96
54 Incidence of variant Creutzfeldt-Jakob disease in the UK. Lancet 2000 0.96
55 How to tackle a possible Creutzfeldt-Jakob disease necropsy. J Clin Pathol 1993 0.96
56 Creutzfeldt-Jakob disease in a dairy farmer. Lancet 1995 0.95
57 Extra-skeletal Ewing's sarcoma of the nasal fossa. J Laryngol Otol 1990 0.95
58 Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease. Neuropathol Appl Neurobiol 2008 0.95
59 RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue. Neuropathol Appl Neurobiol 2011 0.94
60 Superficial epithelioid schwannoma presenting as a subcutaneous upper eyelid mass. Br J Ophthalmol 1994 0.94
61 Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J Neurol Neurosurg Psychiatry 2006 0.93
62 Neuronal apoptosis in fatal familial insomnia. Brain Pathol 1998 0.92
63 Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain 1999 0.92
64 Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie. Neuroreport 2001 0.91
65 A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD). Neuropathol Appl Neurobiol 2009 0.90
66 Third ventricular chordoid glioma: clinicopathological study of two cases with evidence for a poor clinical outcome despite low grade histological features. Neuropathol Appl Neurobiol 2005 0.90
67 Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours. J Neurooncol 1998 0.90
68 High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1996 0.90
69 Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors. Stroke 1999 0.89
70 Paraganglioma of the cauda equina: a histological, ultrastructural and immunocytochemical study of two cases with a review of the literature. J Pathol 1985 0.89
71 Florid plaques and new variant Creutzfeldt-Jakob disease. Lancet 1997 0.89
72 The new variant of Creutzfeldt-Jakob disease. Rev Sci Tech 2000 0.88
73 Inherited Creutzfeldt-Jakob disease in a British family associated with a novel 144 base pair insertion of the prion protein gene. J Neurol Neurosurg Psychiatry 1995 0.88
74 Phase II study of tauromustine in malignant glioma. Eur J Cancer 1992 0.88
75 Demonstration of Epstein-Barr virus in primary brain lymphoma by in situ DNA hybridisation in paraffin wax embedded tissue. J Clin Pathol 1990 0.87
76 Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry 2006 0.87
77 Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res 1990 0.87
78 Retention of corneal epithelial cells following Goldmann tonometry: implications for CJD risk. Br J Ophthalmol 2003 0.87
79 An unusual case of Wilson's disease. Q J Med 1985 0.87
80 True neurilemmoma arising in a lymph node in infancy. Histopathology 1991 0.87
81 In situ hybridization analysis of PrP mRNA in human CNS tissues. Neuropathol Appl Neurobiol 2001 0.86
82 vCJD and the gut: implications for endoscopy. Gut 2007 0.86
83 Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1995 0.86
84 Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids 2002 0.86
85 Variant Creutzfeldt-Jakob disease in an elderly patient. Lancet 2001 0.86
86 Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. Intervirology 1997 0.85
87 Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease. Br J Ophthalmol 2005 0.85
88 Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation. Eye (Lond) 2009 0.84
89 Referral pattern and management of patients with malignant brain tumours in south east Scotland. Health Bull (Edinb) 1996 0.84
90 An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system. Acta Neuropathol 1986 0.84
91 Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow. Acta Neurochir (Wien) 1996 0.83
92 Differences in the density and spatial distribution of florid and diffuse plaques in variant Creutzfeldt-Jakob disease (vCJD). Clin Neuropathol 2003 0.83
93 Reporting of suspect new variant Creutzfeldt-Jakob disease. Lancet 1997 0.83
94 Isolated cervical intramedullary sarcoidosis--a histological surprise. Br J Neurosurg 2004 0.83
95 Investigation of PrPres in dental tissues in variant CJD. Br Dent J 2003 0.83
96 Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2000 0.83
97 The effect of treatment with recombinant human erythropoietin on the histological appearance and glycogen content of skeletal muscle in patients with chronic renal failure treated by regular hospital haemodialysis. Nephron 1993 0.83
98 [Consensus report: tissue handling in suspected Creutzfeldt-Jakob disease and other spongiform encephalopathies (prion diseases) in the human. European Union Biomed-1 Concerted Action]. Pathologe 1996 0.83
99 Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldt-Jakob disease. Neurosci Lett 1995 0.82
100 Sporadic Creutzfeldt-Jakob disease in two adolescents. J Neurol Neurosurg Psychiatry 2007 0.82
101 The prognostic influence of bcl-2 in malignant glioma. Br J Cancer 2002 0.82
102 Variant Creutzfeldt-Jakob disease. Clin Lab Med 2003 0.82
103 Apoptosis in human primary brain tumours: actions of arachidonic acid. Prostaglandins Leukot Essent Fatty Acids 1998 0.82
104 Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients. Neuropathol Appl Neurobiol 2009 0.81
105 Disease-associated prion protein is not detectable in human systemic amyloid deposits. J Pathol 2007 0.81
106 Activation of Fas and caspase 3 precedes PrP accumulation in 87V scrapie. Neuroreport 2001 0.81
107 vCJD: the epidemic that never was. New variant Creutzfeldt-Jakob disease: the critique that never was. BMJ 2002 0.80
108 Creutzfeldt-Jakob disease. Lancet 1996 0.80
109 Amyloid beta-protein length and cerebral amyloid angiopathy-related haemorrhage. Neuroreport 2000 0.80
110 Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty. Vox Sang 2005 0.80
111 Pharmacological comparison of the sigma recognition site labelled by [3H]haloperidol in human and rat cerebellum. Naunyn Schmiedebergs Arch Pharmacol 1992 0.80
112 Monoclonal antibody to aldolase C: a selective marker for Purkinje cells in the human cerebellum. Neuropathol Appl Neurobiol 1987 0.80
113 Squamous cell carcinoma arising in a subcutaneous dermoid cyst. Postgrad Med J 1991 0.80
114 Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies. Neuropathol Appl Neurobiol 2003 0.80
115 Angiotensin II inhibits cortical cholinergic function: implications for cognition. J Cardiovasc Pharmacol 1990 0.79
116 Cerebral metastasis from a malignant mixed müllerian tumour of the uterus. Histopathology 1993 0.79
117 Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial. J Neurol Neurosurg Psychiatry 1998 0.79
118 Prion protein immunohistochemical staining in the brains of monkeys with transmissible spongiform encephalopathy. Neuropathol Appl Neurobiol 1998 0.79
119 Primary intracranial angiosarcoma of the Pineal gland: an unusual cause of recurrent intraventricular haemorrhage and superficial haemosiderosis. Neuropathol Appl Neurobiol 2006 0.79
120 Increasing incidence of CNS primary lymphoma in south-east Scotland. Lancet 1991 0.79
121 Spontaneous spongiform encephalopathy in a monkey. Lancet 1996 0.79
122 Churg-Strauss vasculitis diagnosed on muscle biopsy. J Clin Pathol 2004 0.79
123 Inherited multiple meningiomas: a clinical, pathological and cytogenetic study of an affected family. J Neurol Neurosurg Psychiatry 1986 0.79
124 The choroid plexus carcinomas of childhood: histopathology, immunocytochemistry and clinicopathological correlations. Histopathology 1995 0.79
125 Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy-related hemorrhage. Neurology 2000 0.78
126 Oral infection by the bovine spongiform encephalopathy prion. Proc Natl Acad Sci U S A 1999 0.78
127 Familial prion disease with a novel serine to isoleucine mutation at codon 132 of prion protein gene (PRNP). Neuropathol Appl Neurobiol 2009 0.78
128 Prions and the oral cavity. J Dent Res 2003 0.78
129 Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral glioma. J Neurooncol 1995 0.78
130 Cytogenetic studies in 50 meningiomas. Cancer Genet Cytogenet 1988 0.78
131 Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system. Neuropathol Appl Neurobiol 2003 0.78
132 Immunolocalisation of cytokeratins in the normal and neoplastic human pituitary gland. J Neurol Neurosurg Psychiatry 1987 0.78
133 Retrospective neuropathological review of prion disease in UK haemophilic patients. Thromb Haemost 1998 0.78
134 Pre-menopausal cytomegalovirus oophoritis. Histopathology 1990 0.78
135 Whipple's disease with cerebral involvement. Postgrad Med J 1990 0.77
136 Liver and pituitary abnormalities in Hallervorden-Spatz disease. J Neurol Neurosurg Psychiatry 1989 0.77
137 Identification and distribution of 5-HT3 recognition sites within the human brainstem. Neurosci Lett 1990 0.77
138 Surgical intervention, biopsy and APOE genotype in cerebral amyloid angiopathy-related haemorrhage. Br J Neurosurg 1999 0.77
139 Autoimmune hypothyroidism coexisting with a pituitary adenoma secreting thyroid-stimulating hormone, prolactin and alpha-subunit. Ann Clin Biochem 2001 0.77
140 Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1994 0.77
141 The spatial patterns of prion protein deposits in cases of variant Creutzfeldt-Jakob disease. Acta Neuropathol 2002 0.77
142 Microwave technology in diagnostic neuropathology. J Neurosci Methods 1994 0.77
143 New-variant Creutzfeldt-Jakob disease: the risk of transmission by blood transfusion. Blood Rev 1998 0.77
144 Progesterone receptors in meningiomas: morphometric assessment of vascularity and cellularity on near facsimile cryostat sections. J Clin Pathol 1986 0.77
145 Objective quantification of prion protein in spinal cords of cases of Creutzfeldt-Jakob disease. Anal Cell Pathol 1996 0.77
146 Microsurgical excision of a pontomedullary epidermoid cyst with prepontine extension: case report. Neurosurgery 1996 0.77
147 Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant Creutzfeldt-Jakob disease transmission. Neuropathol Appl Neurobiol 2009 0.77
148 Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1996 0.77
149 Malignant peripheral nerve sheath tumour arising in a schwannoma. Histopathology 1990 0.77
150 Growth hormone-secreting pituitary adenoma of mixed cell type: a histological, ultrastructural and immunocytochemical study. Clin Neuropathol 1986 0.76
151 Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis. Microsc Res Tech 2000 0.76
152 FFI cases from the United Kingdom. Brain Pathol 1998 0.76
153 Quantification of vacuolation ("spongiform change"), surviving neurones and prion protein deposition in eleven cases of variant Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 2002 0.76
154 Primary melanoma of the urinary bladder presenting with intracerebral metastases. Br J Urol 1985 0.76
155 Apoptosis in human primary brain tumours. Br J Neurosurg 1998 0.76
156 Neuropathological phenotype and 'prion protein' genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 1994 0.76
157 The transmissible spongiform encephalopathies (prion diseases): a review for dental surgeons. Int Dent J 2001 0.76
158 Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage. Stroke 2003 0.76
159 Carcinoid tumour arising in a recurrent intradural spinal teratoma. Neuropathol Appl Neurobiol 1985 0.76
160 Self-induced myopathy. Postgrad Med J 1997 0.75
161 Behavioural disturbance and visual hallucinations in a 78 year old man. J Neurol Neurosurg Psychiatry 1998 0.75
162 Atypical cytomegalovirus retinitis: a clinicopathological correlation. Br J Ophthalmol 1994 0.75
163 Diagnosis of Creutzfeldt-Jakob disease. Routine tonsil biopsy for diagnosis of new variant Creutzfeldt-Jakob disease is not justified. BMJ 1999 0.75
164 Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. J Neurol Neurosurg Psychiatry 1996 0.75
165 Screening for variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2003 0.75
166 Paraganglioma of the cauda equina. J Neurol Neurosurg Psychiatry 1988 0.75
167 The pulvinar sign and diagnosis of Creutzfeldt-Jakob disease. Neurology 2002 0.75
168 Neuropathological and neurophysiological effects of interstitial white matter autologous and non-autologous protein containing solutions: further evidence for a glioma derived permeability factor. Acta Neurochir (Wien) 1993 0.75
169 Demonstration of Epstein-Barr virus in primary central nervous system lymphomas. Hum Pathol 1991 0.75
170 New variant Creutzfeldt-Jakob disease is more common in Britain than elsewhere. BMJ 1998 0.75
171 Progressive aphasia with rapidly progressive dementia in a 49 year old woman. J Neurol Neurosurg Psychiatry 1999 0.75
172 Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease. BMJ 1996 0.75
173 Automatic quantification of amyloid plaque formation in human spongiform encephalopathy. Neurodegeneration 1994 0.75
174 Steroid hormone receptors in pituitary adenomas: a biochemical, immunohistochemical and morphometric study on cryostat sections. Neuropathol Appl Neurobiol 1987 0.75
175 Inhibition of prion-protein conversion: a therapeutic tool? Trends Microbiol 2000 0.75
176 Presentation of a case of variant CJD in general dental practice. Br Dent J 2004 0.75
177 Protection of personnel and environment against Creutzfeldt-Jakob disease in pathology laboratories. Clin Exp Pathol 1999 0.75
178 Update on variant Creutzfeldt-Jakob disease. Amyloid 2000 0.75
179 An intramedullary vascular malformation mimicking intrinsic spinal cord tumour. Br J Neurosurg 2006 0.75
180 Kinetics of reactive oxygen intermediate formation and apoptosis in human glioma and glioma C6 cell line: effects of radiation and n-6 essential fatty acids. Biochem Soc Trans 1998 0.75
181 Neuroleptic malignant syndrome in the intensive therapy unit. Anaesthesia 1990 0.75
182 Primary intracerebral lymphoma: a clinicopathological analysis of 14 patients presenting over a 10-year period in Sheffield. Q J Med 1988 0.75
183 Immunolocalization of cathepsin D in the human central nervous system and central nervous system neoplasms. Neuropathol Appl Neurobiol 1990 0.75
184 Toxicity of cyclosporin metabolites. Lancet 1988 0.75
185 Epileptogenic anaplastic astrocytoma imaged only by T2-weighted magnetic resonance studies: clinical and surgical implications. Br J Neurosurg 1992 0.75
186 Brain biopsy and patients with atypical presentations of sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1997 0.75
187 Creutzfeldt-Jakob disease in a beef farmer. Lancet 1996 0.75
188 Accuracy of ventrolateral thalamic nucleus localization using unreformatted CT scans and the B-R-W system. Experimental studies and clinical findings during functional neurosurgery. Acta Neurochir Suppl (Wien) 1993 0.75
189 Cutaneous malignant melanoma metastatic to the choroid: a clinicopathological case report. Eye (Lond) 1995 0.75
190 Size frequency distributions of the florid prion protein aggregates in variant Creutzfeldt-Jakob disease follow a power-law function. Neurol Sci 2006 0.75
191 Glioma cells transduced with selection transgenes may not form gliomas in vivo and can also inhibit glioma formation by admixed wild glioma cell lines. Acta Neurochir Suppl 1997 0.75
192 From slow virus to prion. Histopathology 1992 0.75
193 Spatial correlation between the vacuolation, prion protein, deposition and surviving neurons in patients with Creutzfeldt-Jakob disease (vCJD). J Neural Transm (Vienna) 2003 0.75
194 Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland. Lancet 1996 0.75
195 A new index of agonal state for neurological disease. Neuropathol Appl Neurobiol 2011 0.75
196 Principles and practice of 'high risk' brain banking. Neuropathol Appl Neurobiol 1997 0.75
197 An experimental study to evaluate the accuracy of diencephalic and pallidal target localization using the Brown-Roberts-Wells stereotactic system and unreformatted axial GE8800 CT scanning. Br J Neurosurg 1994 0.75
198 The galactocoele: a light- and electronmicroscopic study. Histopathology 1985 0.75
199 Lymphomatoid granulomatosis with cerebral involvement. Neuropathol Appl Neurobiol 1985 0.75
200 Macrophage and microglial cell immunoreactivity for PrP(c) in a random post-mortem population. Neuropathol Appl Neurobiol 2002 0.75
201 Does the neuropathology of human patients with variant Creutzfeldt-Jakob disease reflect haematogenous spread of the disease? Neurosci Lett 2003 0.75
202 A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-Jakob disease using four anti prion protein antibodies. Neurodegeneration 1996 0.75
203 Network analysis of arachidonic acid pathophysiology in human phagocytes and primary brain tumors. Ann N Y Acad Sci 1997 0.75
204 [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone]. Ned Tijdschr Geneeskd 1996 0.75
205 Novel application of image analysis to the detection of spongiform change. Anal Quant Cytol Histol 1994 0.75
206 Primary pituitary abscess: surgical management and endocrine assessment in three cases. Br J Neurosurg 1989 0.75
207 Spinal cord pathology and viral burden in homosexuals and drug users with AIDS. Neuropathol Appl Neurobiol 1999 0.75
208 Creutzfeldt-Jakob disease in a young person with valine homozygosity at codon 129: sporadic or variant? J Neurol Neurosurg Psychiatry 2001 0.75
209 Characterisation of [3H]ceranapril recognition sites in rat and human brain tissue. Neuropharmacology 1991 0.75
210 Creutzfeldt-Jakob disease presenting as recurrent falls in an older person. Age Ageing 2001 0.75
211 In situ hybridization in neuropathology. Neuropathol Appl Neurobiol 1994 0.75
212 Size frequency distribution of prion protein (PrP) aggregates in variant Creutzfeldt-Jakob disease (vCJD). J Neural Transm (Vienna) 2005 0.75
213 The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex. Brain Res Bull 1990 0.75
214 Mikulicz syndrome and disease: 2 case reports highlighting the difference. Acta Ophthalmol (Copenh) 1993 0.75
215 New variant Creutzfeldt-Jakob disease. Curr Opin Neurol 1998 0.75